Form 8-K - Current report:
SEC Accession No. 0000950170-24-127099
Filing Date
2024-11-14
Accepted
2024-11-14 16:25:06
Documents
14
Period of Report
2024-11-14
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pkbo-20241114.htm   iXBRL 8-K 83784
2 EX-2.2 pkbo-ex2_2.htm EX-2.2 29119
3 EX-3.1 pkbo-ex3_1.htm EX-3.1 18802
4 EX-3.2 pkbo-ex3_2.htm EX-3.2 136988
  Complete submission text file 0000950170-24-127099.txt   459455

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT pkbo-20241114.xsd EX-101.SCH 51436
17 EXTRACTED XBRL INSTANCE DOCUMENT pkbo-20241114_htm.xml XML 6836
Mailing Address 4900 HOPYARD ROAD, SUITE 100 PLEASANTON CA 94588
Business Address 4900 HOPYARD ROAD, SUITE 100 PLEASANTON CA 94588 (925) 463-4800
Peak Bio, Inc. (Filer) CIK: 0001834645 (see all company filings)

EIN.: 852448157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39951 | Film No.: 241462898
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)